Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.
P3 Health Partners Inc. reports developments in population health management, value-based primary care and physician-led care coordination. The company supports community providers through administrative services, clinical operations, data-driven care enablement and partnerships tied to Medicare Advantage, accountable care organizations and delegated-risk arrangements.
Recurring updates include quarterly results, guidance, revenue trends, capitated revenue per member, medical margin, adjusted EBITDA and operating changes in the Care Enablement Model. Company news also covers payer and provider agreements, ACO management services, market expansion, investor conference participation and joint venture activity such as the P3 Commonwealth Innovation MSO.
P3 Health Partners (NASDAQ: PIII) reported first quarter 2026 results and raised full-year adjusted EBITDA guidance. Q1 at-risk membership was about 106,000, down 10%, with 135,000 total lives under management.
Total revenue reached $386 million, up 4% year over year. Medical margin was $73.7 million ($231 PMPM), or $56.1 million excluding prior-year development and payer settlements. Net income was $3.0 million versus a $44.2 million loss a year earlier. Adjusted EBITDA was $25.8 million ($81 PMPM). Full-year 2026 guidance now includes revenue of $1.5–$1.65 billion and adjusted EBITDA of $20–$60 million.
P3 Health Partners (NASDAQ: PIII) will release first quarter 2026 financial results on May 14, 2026 and host a conference call the same day at 1:30pm PT / 4:30pm ET. The call will be webcast live and archived for 90 days on the company's Investor page.
Dial‑in details and webcast access will be posted on the Investor page in advance, and the press release will be made available prior to the call.
P3 Health Partners (NASDAQ: PIII) reported Q4 and full-year 2025 results and provided 2026 guidance. Management forecasted $-20M to $40M Adjusted EBITDA with a midpoint of $10M, implying ~$170M year-over-year EBITDA improvement. Full-year revenue was $1.46B; adjusted EBITDA loss improved to $161.3M from $167.2M in 2024 (normalized improvement $43.9M).
At-risk membership declined to ~116,000 (down ~8%), capitated revenue PMPM rose to $1,026, and management emphasized a path to profitability and disciplined contract alignment.
P3 Health Partners (NASDAQ: PIII) will release fourth quarter and full year 2025 financial results on March 26, 2026.
Management will host a conference call at 1:30pm PT / 4:30pm ET on March 26, 2026, available by phone and live webcast at ir.p3hp.org. An archived recording will remain on the investor site for 90 days.
P3 Health Partners (NASDAQ: PIII) and Commonwealth Primary Care ACO announced a joint venture management services organization on December 2, 2025 to expand value-based care for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina.
The JV preserves independent ACO entities, places P3 as the majority owner, and creates a unified operational platform combining P3’s Medicare Advantage/ACO/delegated risk capabilities with Commonwealth’s ACO REACH experience, while expanding P3’s footprint into Maricopa County, Arizona.
P3 Health Partners (NASDAQ: PIII) announced management will present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 3:30 p.m. ET.
A live webcast of the presentation will be available on P3's investor relations website at https://ir.p3hp.org/. The presentation offers investors a chance to hear management remarks and a company update directly at the conference.
Summary not available.
P3 Health Partners (NASDAQ: PIII) will release third quarter 2025 financial results and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. Management will discuss results on a conference call at 5:00 AM PT / 8:00 AM ET the same day. The call is toll-free at 1-833-316-0546 (US) or 1-412-317-0692 (international), and will be webcast live from the company's Investor page at ir.p3hp.org.
The press release will be posted on the Investor page in advance of the call. An archived recording of the webcast will be available on the Investor page for 90 days after the conference call.
P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the upcoming Jefferies Healthcare Services Conference. The company's management team will engage in a fireside chat on September 30, 2025, at 2:25 PM Central Time.
Investors can access the presentation via webcast on P3's Investor Relations website, with a replay available for 30 days following the event.
Catalyst Solutions (NYSE:PIII) has successfully launched its Professional Health Partners Services (P3) Implementation across four states. The implementation, completed in May 2025, supports P3 Health Partners in delivering population health management and administrative services for Medicare members.
The project spans Arizona, Oregon, Nevada, and California, covering eleven active health plans and serving nearly 68,000 members. Catalyst provides support through Configurations, Claims, and Provider Call Center services using a hybrid onshore/offshore model. The implementation was notably completed in just 60 days, demonstrating Catalyst's efficient execution capabilities.